Association of concurrent porcine circovirus (PCV) 2a and 2b infection with PCV associated disease in vaccinated pigs

Research in Veterinary Science

Volumn 95, Issue 2, 2013, Pages 775-781

  Gerber, Priscilla F ^a,b   Johnson, John ^a   Shen, Huigang ^a   Striegel, Dave ^c   Xiao, Chao Ting ^a   Halbur, Patrick G ^a   Opriessnig, Tanja ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Animal Health Center   (United States)

Author keywords

Co infection; Porcine circovirus 2; Porcine circovirus associated disease

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS DNA; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIRCOVIRIDAE INFECTION; CIRCOVIRUS; DRUG EFFICACY; HERD; IMMUNE RESPONSE; MYCOPLASMA HYOPNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; SWINE DISEASE; TREATMENT FAILURE; VIRUS DETECTION; VIRUS REPLICATION;

MYCOPLASMA HYOPNEUMONIAE; PORCINE CIRCOVIRUS; PORCINE CIRCOVIRUS 2; SUIDAE;

CO-INFECTION; PORCINE CIRCOVIRUS 2; PORCINE CIRCOVIRUS ASSOCIATED DISEASE;

ANIMALS; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; DISEASE OUTBREAKS; PHYLOGENY; SWINE; SWINE DISEASES; UNITED STATES; VIRAL VACCINES;

EID: 84881554635     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2013.06.004     Document Type: Article

References (34)

1. Bereiter M., Young T.F., Joo H.S., Ross R.F. Evaluation of the ELISA and comparison to the complement fixation test and radial immunodiffusion enzyme assay for detection of antibodies against Mycoplasma hyopneumoniae in swine serum. Veterinary Microbiology 1990, 25:177-192.
2. Cai L., Ni J., Xia Y., Zi Z., Ning K., Qiu P., Li X., Wang B., Liu Q., Hu D., Yu X., Zhou Z., Zhai X., Han X., Tian K. Identification of an emerging recombinant cluster in porcine circovirus type 2. Virus Research 2012, 165:95-102.
3. Cheung A.K., Lager K.M., Kohutyuk O.I., Vincent A.L., Henry S.C., Baker R.B., Rowland R.R., Dunham A.G. Detection of two porcine circovirus type 2 genotypic groups in United States swine herds. Archives of Virology 2007, 152:1035-1044.
4. Dupont K., Hjulsager C.K., Kristensen C.S., Baekbo P., Larsen L.E. Transmission of different variants of PCV2 and viral dynamics in a research facility with pigs mingled from PMWS-affected herds and non-affected herds. Veterinary Microbiology 2009, 18:219-226.
5. Dupont K., Nielsen E.O., Baekbo P., Larsen L.E. Genomic analysis of PCV2 isolates from Danish archives and a current PMWS case-control study supports a shift in genotypes with time. Veterinary Microbiology 2008, 128:56-64.
6. Fachinger V., Bischoff R., Jedidia S.B., Saalmüller A., Elbers K. The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex. Vaccine 2008, 26:1488-1499.
7. Fenaux M., Halbur P.G., Gill M., Toth T.E., Meng X.J. Genetic characterization of type 2 porcine circovirus (PCV-2) from pigs with postweaning multisystemic wasting syndrome in different geographic regions of North America and development of a differential PCR-restriction fragment length polymorphism assay to detect and differentiate between infections with PCV-1 and PCV-2. Journal of Clinical Microbiology 2000, 38:2494-2503.
8. Fort M., Sibila M., Allepuz A., Mateu E., Roerink F., Segalés J. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Vaccine 2008, 26:1063-1071.
9. Gagnon C.A., Tremblay D., Tijssen P., Venne M.H., Houde A., Elahi S.M. The emergence of porcine circovirus 2b genotype (PCV-2b) in swine in Canada. Canadian Veterinary Journal 2007, 48:811-819.
10. Gauger P.C., Faaberg K.S., Guo B., Kappes M.A., Opriessnig T. Genetic and phenotypic characterization of a 2006 United States porcine reproductive and respiratory virus isolate associated with high morbidity and mortality in the field. Virus Research 2012, 163:98-107.
11. Grau-Roma L., Crisci E., Sibila M., López-Soria S., Nofrarías M., Cortey M., Fraile L., Olvera A., Segalés J. A proposal on porcine circovirus type 2 (PCV2) genotype definition and their relation with postweaning multisystemic wasting syndrome (PMWS) occurrence. Veterinary Microbiology 2008, 128:23-35.
12. Guo L., Fu Y., Wang Y., Lu Y., Wei Y., Tang Q., Fan P., Liu J., Zhang L., Zhang F., Huang L., Liu D., Li S., Wu H., Liu C. A porcine circovirus type 2 (PCV2) mutant with 234 amino acids in capsid protein showed more virulence in vivo, compared with classical PCV2a/b strain. PLoS One 2012, 7:e41463.
13. Guo L., Lu Y., Wei Y., Huang L., Wu H., Liu C. Porcine circovirus genotype 2a (PCV2a) and genotype 2b (PCV2b) recombinant mutants showed significantly enhanced viral replication and altered antigenicity in vitro. Virology 2011, 419:57-63.
14. Harding J.C., Ellis J.A., McIntosh K.A., Krakowka S. Dual heterologous porcine circovirus genogroup 2a/2b infection induces severe disease in germ-free pigs. Veterinary Microbiology 2010, 145:209-219.
15. Harmon K., Abate S., Chriswell A., Chittick W., Strait E. Comparison of two commercial real-time reverse transcriptase polymerase chain reactions for porcine reproductive and respiratory syndrome virus. Journal of Swine Health and Production 2012, 20:184-188.
16. Hesse R., Kerrigan M., Rowland R.R. Evidence for recombination between PCV2a and PCV2b in the field. Virus Research 2008, 132:201-207.
17. Holtkamp D.J., Polson D., Torremorell M., Morrison R.B., Classen D.M., Henry S., Rodibaugh M.T., Rowland R., Snelson H., Straw B., Yeske P., Zimmerman J. Terminology for classifying the porcine reproductive and respiratory syndrome virus (PRRSV) status of swine herds. Journal of Swine Health and Production 2011, 19:44-56.
18. Khaiseb S., Sydler T., Zimmermann D., Pospischil A., Sidler X., Brugnera E. Porcine circovirus 2 major genotype group members co-replication as a prerequisite to co-evolution that may explain the variable disease manifestations. Journal of Virology 2011, 85:11111-11120.
19. Kim D., Ha Y., Oh Y., Chae C. Prevalence of porcine circovirus types 2a and b in pigs with and without post-weaning multi-systemic wasting syndrome. Veterinary Journal 2011, 188:115-117.
20. Kixmöller M., Ritzmann M., Eddicks M., Saalmüller A., Elbers K., Fachinger V. Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2. Vaccine 2008, 26:3443-3451.
21. Kuehn, T., Sondermeijer, P., Eggen, A., Fiebig, K., Von Rueden, S., 2011. Development of a new marker ELISA (BacuCheck™) for compliance testing following the vaccination of piglets against PCV2. In: 6th International Symposium on Emerging and Re-emerging Pig Diseases, 42.
22. Lager K.M., Gauger P.C., Vincent A.L., Opriessnig T., Kehrli M.E., Cheung A.K. Mortality in pigs given porcine circovirus type 2 subgroup 1 and 2 viruses derived from DNA clones. Veterinary Record 2007, 161:428-429.
23. Larochelle R., Magar R., D'Allaire S. Genetic characterization and phylogenetic analysis of porcine circovirus type 2 (PCV2) strains from cases presenting various clinical conditions. Virus Research 2002, 90:101-112.
24. Opriessnig T., Gauger P.C., Faaberg K.S., Shen H., Beach N.M., Meng X.J., Wang C., Halbur P.G. Effect of porcine circovirus type 2a or 2b on infection kinetics and pathogenicity of two genetically divergent strains of porcine reproductive and respiratory syndrome virus in the conventional pig model. Veterinary Microbiology 2012, 158:69-81.
25. Opriessnig T., Meng X.J., Halbur P.G. Porcine circovirus type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. Journal Veterinary Diagnostic Investigation 2007, 19:591-615.
26. Opriessnig T., Patterson A.R., Madson D.M., Pal N., Halbur P.G. Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2-3-months post vaccination. Vaccine 2009, 27:1002-1007.
27. Opriessnig T., Ramamoorthy S., Madson D.M., Patterson A.R., Pal N., Carman S., Meng X.J., Halbur P.G. Differences in virulence among porcine circovirus type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides heterologous protection. Journal of General Virology 2008, 89:2482-2491.
28. Opriessnig T., Xiao C., Gerber P.F., Halbur P.G. Emergence of a novel mutant PCV2b variant associated with clinical PCVAD in two vaccinated pig farms in the U.S. concurrently infected with PPV2. Veterinary Microbiology 2013, 163:177-183.
29. Patterson A.R., Opriessnig T. Epidemiology and horizontal transmission of porcine circovirus type 2 (PCV2). Animal Health Research Reviews 2010, 11:217-234.
30. Pejsak Z., Podgorska K., Truszczynski M., Karbowiak P., Stadejek T. Efficacy of different protocols of vaccination against porcine circovirus type 2 (PCV2) in a farm affected by postweaning multisystemic wasting syndrome (PMWS). Comparative Immunology, Microbiology, and Infectious Diseases 2010, 33:e1-e5.
31. Pogranichniy R.M., Yoon K.J., Harms P.A., Swenson S.L., Zimmerman J.J., Sorden S.D. Characterization of immune response of young pigs to porcine circovirus type 2 infection. Viral Immunology 2000, 13:143-153.
32. Segalés J., Urniza A., Alegre A., Bru T., Crisci E., Nofrarías M., López-Soria S., Balasch M., Sibila M., Xu Z., Chu H.J., Fraile L., Plana-Duran J. A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms. Vaccine 2009, 27:7313-7321.
33. Shen H.G., Halbur P.G., Opriessnig T. Prevalence and phylogenetic analysis of the current PCV2 genotypes after implementation of widespread vaccination programs in the United States. Journal of General Virology 2012, 93:1345-1355.
34. Zhai S.L., Chen S.N., Wei Z.Z., Zhang J.W., Huang L., Lin T., Yue C., Ran D.L., Yuan S.S., Wei W.K., Long J.X. Co-existence of multiple strains of porcine circovirus type 2 in the same pig from China. Virology Journal 2011, 8:517.